Religare Enterprises Reports H1 FY27 Performance with Strong Subsidiary Growth
Religare Enterprises Ltd · Press Release · 13 Nov 2026, 12:59 am
Religare Enterprises Reports H1 FY27 Performance with Strong Subsidiary Growth Religare Enterprises posted total consolidated income of ₹4,717 crore in H1 FY27, up 19% YoY from ₹3,965 crore in H1 FY26. Key subsidiary Care Health Insurance delivered a 35% YoY increase in GWP to ₹6,897 crore, with PBT expanding 42% YoY to ₹392 crore. Religare Finvest posted a 33% YoY PAT growth to ₹64.5 crore, backed by strong recoveries, and restarted retail lending in Nov'26 post-CAP removal. Additionally, an independent legacy governance review by Trilegal confirmed no adverse financial impacts on the company.
Original exchange filing (PDF)
More announcements from Religare Enterprises Ltd
- Audio Recording of earnings call held on Friday, November 13, 2026 at 04.00 P.M. IST · 14 Nov 2026
- Monitoring Agency Report for the quarter ended September 30, 2026 · 14 Nov 2026
- Investor Presentation for Quarter and half year ended September 30, 2026 · 13 Nov 2026
- Grant of Stock Options · 13 Nov 2026
- Update on the governance review · 13 Nov 2026
- Un-Audited Financial Results (Standalone & Consolidated) of the Company which have been subjected to Limited Review by the Statutory Auditors for the quarter and half year ended September 30, 2026 · 13 Nov 2026
- Religare Enterprises Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 13 Nov 2026
- Un-Audited Financial Results (Standalone & Consolidated) of the Company which have been subjected to Limited Review by the Statutory Auditors for the quarter and half year ended September 30, 2026 · 13 Nov 2026
